Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results

被引:0
|
作者
Liu, Xianying [1 ]
Mcgrath, Daniel [2 ]
Ohlrich, Kelly [3 ]
Chen, Frederick Y. [4 ]
Lee, Lawrence S. [4 ]
Robich, Michael [5 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Anesthesiol, Portland, OR USA
[2] Columbia Univ, Stamford Hosp, Dept Surg, Stamford, CT USA
[3] Med Univ South Carolina, Dept Cardiothorac Surg, Charleston, SC USA
[4] Tufts Med Ctr, Dept Cardiac Surg, Boston, MA USA
[5] John Hopkins Med, Div Cardiac Surg, Baltimore, MD 21224 USA
关键词
elongated mitral valve leaflets; hypertrophic cardiomyopathy; mitral valve plication; septal myectomy; MYECTOMY;
D O I
10.1155/2024/7078246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertrophic cardiomyopathy (HCM) is commonly associated with mitral valve pathology. A large majority of patients with HCM have elongated anterior and posterior mitral leaflets. There remains debate regarding the necessity and role of concomitant mitral valve surgery at the time of septal myectomy. We aimed to describe the characteristics and share our surgical experiences with this specific group of patients.Methods: This retrospective single-center study investigates adult patients with HCM, with or without elongated mitral valve leaflets (MVLs), who underwent elective septal myectomy with or without concomitant mitral valve intervention, between January 1, 2016, and June 30, 2020. Clinical data were obtained from institutional medical records as well as the Society of Thoracic Surgeons data registry. The clinical characteristics and in-hospital surgical outcomes were compared between patients with an elongated MVL and those without.Results: In total, 379 patients underwent septal myectomy, and 22 patients with intrinsic mitral valve disease were excluded. In addition, 23 patients were excluded due to missing data. Of the remaining 334 patients, 131 (39.2%) had elongated MVL and concomitant MVL plication. Patients with elongated MVL had higher rates of preoperative mitral valve systolic anterior motion (SAM) (94.7% vs. 86.7%, p=0.019) and higher preoperative provoked left ventricular outflow tract gradient (LVOTG) (134.5 mmHg versus 125.3 mmHg, p=0.046). Post septal myectomy and mitral valve plication, they had lower rates of postoperative residual mitral regurgitation (3.8% vs. 12.8%, p=0.006), comparable rates of residual SAM (28.2% vs. 31.5%, p = 0.524), postoperative provoked LVOTG (15.4 mmHg vs. 14.0 mmHg, p=0.317), 30-day major adverse cardiopulmonary events (2.3% vs. 3.9%, p=0.409), and mortality (0% vs. 1.0%, p=0.255).Conclusions: Elongated MVLs contribute more significantly to dynamic LVOT obstruction, as evidenced during provocative testing. Concomitant mitral valve intervention during septal myectomy can be performed safely and may provide an effective strategy to resolve SAM and stress-induced LVOTG.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Surgical Strategy of Mitral Valve Repair in Transmitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy
    Tan, Tong
    Liu, Jian
    Zhu, Wei
    Guo, Huiming
    THORACIC AND CARDIOVASCULAR SURGEON, 2023, 71 (03): : 178 - 179
  • [22] Mitral valve replacement for three cases of hypertrophic obstructive cardiomyopathy--surgical treatment
    Koh Y.
    Okubo T.
    Hoshino R.
    Kamigaki Y.
    Ouchi S.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (8): : 747 - 752
  • [23] Abnormal mitral valve apparatus is not an indication for mitral valve replacement in hypertrophic obstructive cardiomyopathy
    Varma, Praveen Kerala
    Ahamed, Hisham
    ANNALS OF CARDIAC ANAESTHESIA, 2020, 23 (02) : 246 - 247
  • [24] Long anterior mitral valve leaflets determine the development of dynamic left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
    Lindqvist, G. Per
    Henein, M. Y.
    Gustavsson, S.
    Morner, S.
    Backman, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 60 - 60
  • [25] ABNORMAL MITRAL-VALVE COAPTATION IN HYPERTROPHIC CARDIOMYOPATHY
    SHAH, PM
    TAYLOR, RD
    WONG, M
    CIRCULATION, 1979, 60 (04) : 77 - 77
  • [26] Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy
    Hong, Joon Hwa
    Nguyen, Anita
    Schaff, Hartzell Vernon
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 36 (Suppl 1) : 34 - 43
  • [27] Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy
    Joon Hwa Hong
    Anita Nguyen
    Hartzell Vernon Schaff
    Indian Journal of Thoracic and Cardiovascular Surgery, 2020, 36 : 34 - 43
  • [28] Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management
    C. Charles Jain
    Darrell B. Newman
    Jeffrey B. Geske
    Current Cardiology Reports, 2019, 21
  • [29] PERCUTANEOUS MITRAL VALVE REPAIR FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Modi, Vivek Amit
    Shah, Kashyap
    Shirani, Jamshid
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 863 - 863
  • [30] The Mitral Valve in Hypertrophic Cardiomyopathy It's a Long Story
    Woo, Anna
    Jedrzkiewicz, Sean
    CIRCULATION, 2011, 124 (01) : 9 - 12